Doxokebir®
Doxorubicin
Therapeutic action
Antineoplastic
Indications
Gastric cancer, Thyroid Cancer, Breast Cancer, Lung cancer, Ovarian cancer, Bladder cancer, Acute lymphoblastic leukemia, Acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, Neuroblastoma, Soft tissue and bone sarcomas, Wilms’ tumor
Presentation
Lyophilized Injectable of 10 mg and 50 mg